The Academic Drug Discovery Consortium invites you to hear about the latest ideas in small-molecule library development at, “Better Leads, Better Drugs: Innovations in Screening Libraries.” Scientists engaged in drug discovery and chemical biology know that a screen is only as good as the molecules that go into it. But with the vast potential chemical space, how do you decide what to include in your virtual, high-throughput, or fragment-based screens? This event will bring together drug-seekers from academia and industry focused on the application of new technologies and computational tools to tackle this question in order to deliver higher quality leads. This 1.5-day meeting will create a dynamic, interactive environment for presentations and discussion, and also includes a ½-day networking session for one on one partnering meetings between participants.
Topics: DNA-encoded libraries, Targeted Protein Degradation, RNA binding Drugs, 1Billion-compound virtual libraries, Kinase profiling, Fragment libraries, Macrocycles, Repurposing and MOA libraries, Innovative Compound libraries, Round table discussion topics: Sharing libraries among academics, Informatics including data management flow, Virtual screening software tools and open source software, Academic Drug Discovery Consortium